XML 47 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 29, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Allocated Employee Stock-Based Compensation Expense
We recorded and allocated employee stock-based compensation expense for our equity incentive plans and our 2000 Employee Stock Purchase Plan (“ESPP”) as follows (in thousands):
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Research and development
$
2,900

 
$
1,600

 
$
5,933

 
$
3,078

Selling, general and administrative
6,383

 
3,427

 
12,655

 
6,662

Total stock-based compensation
$
9,283

 
$
5,027

 
$
18,588

 
$
9,740

Weighted Average Grant-Date Fair Value of Stock Options and ESPP Purchases
We use the Black-Scholes Merton option pricing model to value our stock options and ESPP purchases. The weighted average grant-date fair value per share of our stock options and ESPP purchases was as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Stock options
$
9.82

 
$
10.07

 
$
10.37

 
$
10.01

ESPP
$
6.84

 
$
5.65

 
$
7.17

 
$
4.61

Valuation Assumptions Used to Estimate Grant-Date Fair Value
The grant-date fair value of employee stock option grants and ESPP purchases was estimated using the following assumptions:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Stock options:
 
 
 
 
 
 
 
Risk-free interest rate
2.66
%
 
1.72
%
 
2.60
%
 
1.68
%
Dividend yield
%
 
%
 
%
 
%
Volatility
54
%
 
60
%
 
54
%
 
61
%
Expected life
4.5 years

 
4.3 years

 
4.4 years

 
4.2 years

ESPP:
 
 
 
 
 
 
 
Risk-free interest rate
1.80
%
 
0.94
%
 
1.63
%
 
0.77
%
Dividend yield
%
 
%
 
%
 
%
Volatility
52
%
 
60
%
 
52
%
 
64
%
Expected life
6 months

 
6 months

 
6 months

 
6 months

Stock Option Activity
Stock option activity for the six months ended June 30, 2018 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Exercise Price Per Share
 
Weighted
Average
Remaining Contractual
Term
 
Aggregate
Intrinsic
Value
Options outstanding at December 31, 2017
22,208,446

 
$
6.83

 
 
 
 
Granted
818,842

 
$
22.63

 
 
 
 
Exercised
(1,141,640
)
 
$
5.74

 
 
 
 
Forfeited
(102,177
)
 
$
15.20

 
 
 
 
Options outstanding at June 30, 2018
21,783,471

 
$
7.44

 
3.8 years
 
$
312,900

Exercisable at June 30, 2018
16,249,965

 
$
4.80

 
3.2 years
 
$
271,709

RSU Activity
RSU activity for the six months ended June 30, 2018 was as follows (dollars in thousands, except per share amounts):
 
Shares
 
Weighted
Average
Grant Date
Fair Value Per Share
 
Weighted
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
RSUs outstanding at December 31, 2017
3,762,990

 
$
17.76

 
 
 
 
Awarded
300,670

 
$
23.35

 
 
 
 
Vested and released
(341,572
)
 
$
7.75

 
 
 
 
Forfeited
(120,886
)
 
$
19.81

 
 
 
 
RSUs outstanding at June 30, 2018
3,601,202

 
$
19.11

 
1.7 years
 
$
77,498